2024 annual financial data
Eupraxia Pharmaceuticals 2024 Operating margin
Eupraxia Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -26,985,284 USD and net income was -25,485,416 USD.
Operating cash flow was -29,994,491 USD.
Get free Eupraxia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,985,284 USD
- Net income
- -25,485,416 USD
- Operating cash flow
- -29,994,491 USD